Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesEtanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection
Clinical and Experimental Dermatology, 09/10/09
Wu JJ et al. – Patients with psoriasis and chronic hepatitis C virus (HCV) infection are a therapeutic challenge. Systemic psoriasis treatment with methotrexate and acitretin can be hepatotoxic, and interferon (IFN)–alpha for treatment of HCV can worsen psoriasis. Etanercept can be successfully used in patients with psoriasis and HCV.
Related Articles
Acute hepatitis C and HIV coinfection
The Lancet Infectious Diseases, 11/19/09
Relevance Score: 82%
Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease
JAMA, 11/12/09
Relevance Score: 82%
Predictors of Complication after Percutaneous Ultrasound-Guided Kidney Biopsy in HIV-Infected Individuals: Possible Role of Hepatitis C and HIV Co-infection
Clinical Journal of the American Society of Nephrology, 11/05/09
Relevance Score: 82%
The HLA-ER/HLA-ER Genotype Affects the Natural Course of Hepatitis C Virus (HCV) Infection and Is Associated with HLA-E–Restricted Recognition of an HCV-Derived Peptide by Interferon[gamma]–Secreting Human CD8+ T Cells
The Journal of Infectious Diseases, 10/14/09
Relevance Score: 81%
GPs key in hepatitis C campaign
Internet Source, 10/12/09
Relevance Score: 81%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
Alimentary Pharmacology and Therapeutics, 12/16/09
Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
Transplantation Proceedings, 12/16/09
The Benefits of Interferon Treatment in Patients Without Sustained Viral Response After Living Donor Liver Transplantation for Hepatitis C
Transplantation Proceedings, 12/16/09
Article Search
Sponsor